1.
Full Text
Assessment of clinical signs of atopic dermatitis: A systematic review and recommendation
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 132, Issue 6, pp. 1337 - 1347
Background Clinical signs are a core outcome domain for atopic dermatitis (AD) trials. The current lack of standardization of outcome measures in AD trials...
Allergy and Immunology | Atopic dermatitis | severity of illness index | reliability | validity | systematic review | evidence-based medicine | responsiveness | ADULT PATIENTS | BODY-SURFACE AREA | IMMUNOLOGY | DISEASE-ACTIVITY | OUTCOME MEASURES | ADMINISTERED ECZEMA AREA | ALLERGY | PATIENT-ORIENTED SCORAD | OBJECTIVE SEVERITY ASSESSMENT | QUALITY-OF-LIFE | SCORING SYSTEM | METHODOLOGICAL QUALITY | Dermatitis, Atopic - diagnosis | Severity of Illness Index | Reproducibility of Results | Animals | Humans | Dermatitis, Atopic - immunology | Clinical Trials as Topic | Evidence-Based Medicine | Observer Variation | Practice Guidelines as Topic | Public health | Diagnosis | Validity | Quality standards | Signs | Medical treatment | Older people | Dermatitis | Validation studies | Medical and Health Sciences | Medicin och hälsovetenskap | Public Health, Global Health, Social Medicine and Epidemiology | Hälsovetenskaper | Public Health Science | Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi | Health Sciences | Folkhälsovetenskap
Allergy and Immunology | Atopic dermatitis | severity of illness index | reliability | validity | systematic review | evidence-based medicine | responsiveness | ADULT PATIENTS | BODY-SURFACE AREA | IMMUNOLOGY | DISEASE-ACTIVITY | OUTCOME MEASURES | ADMINISTERED ECZEMA AREA | ALLERGY | PATIENT-ORIENTED SCORAD | OBJECTIVE SEVERITY ASSESSMENT | QUALITY-OF-LIFE | SCORING SYSTEM | METHODOLOGICAL QUALITY | Dermatitis, Atopic - diagnosis | Severity of Illness Index | Reproducibility of Results | Animals | Humans | Dermatitis, Atopic - immunology | Clinical Trials as Topic | Evidence-Based Medicine | Observer Variation | Practice Guidelines as Topic | Public health | Diagnosis | Validity | Quality standards | Signs | Medical treatment | Older people | Dermatitis | Validation studies | Medical and Health Sciences | Medicin och hälsovetenskap | Public Health, Global Health, Social Medicine and Epidemiology | Hälsovetenskaper | Public Health Science | Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi | Health Sciences | Folkhälsovetenskap
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2010, Volume 5, Issue 1, p. e8935
Wild waterfowl, particularly dabbling ducks such as mallards (Anas platyrhynchos), are considered the main reservoir of low-pathogenic avian influenza viruses...
A VIRUS | FEBRILE RESPONSE | IMMUNE-RESPONSE | H5N1 | REPLICATION | ANAS-PLATYRHYNCHOS | MULTIDISCIPLINARY SCIENCES | NORTHERN EUROPE | HEART-RATE | WILD BIRDS | DUCKS | Influenza A virus - physiology | Animals | Enzyme-Linked Immunosorbent Assay | Ducks - virology | Influenza in Birds - virology | Influenza A virus - isolation & purification | Virus Shedding | Disease Vectors | Influenza A virus - classification | Reverse Transcriptase Polymerase Chain Reaction | Avian influenza | Viral antibodies | Heart beat | Disease transmission | Avian influenza viruses | Antibodies | Ducks | Shedding | Temperature | Pandemics | Laboratories | Congeners | Bird migration | Animal diseases | Viruses | Biology | Infections | Aquatic birds | Immunity | Epidemiology | Avian flu | Inoculation | Immunology | Blood pressure | Excretion | Waterfowl | Biotelemetry | Body temperature | Ecology | Telemetry | Disease control | Esophagus | Zoonoses | Heart rate | Studies | Experimental infection | Infectious diseases | Influenza | Wildfowl | Aircraft | Biological Sciences | Biologi | Naturvetenskap | Natural Sciences | Biologiska vetenskaper
A VIRUS | FEBRILE RESPONSE | IMMUNE-RESPONSE | H5N1 | REPLICATION | ANAS-PLATYRHYNCHOS | MULTIDISCIPLINARY SCIENCES | NORTHERN EUROPE | HEART-RATE | WILD BIRDS | DUCKS | Influenza A virus - physiology | Animals | Enzyme-Linked Immunosorbent Assay | Ducks - virology | Influenza in Birds - virology | Influenza A virus - isolation & purification | Virus Shedding | Disease Vectors | Influenza A virus - classification | Reverse Transcriptase Polymerase Chain Reaction | Avian influenza | Viral antibodies | Heart beat | Disease transmission | Avian influenza viruses | Antibodies | Ducks | Shedding | Temperature | Pandemics | Laboratories | Congeners | Bird migration | Animal diseases | Viruses | Biology | Infections | Aquatic birds | Immunity | Epidemiology | Avian flu | Inoculation | Immunology | Blood pressure | Excretion | Waterfowl | Biotelemetry | Body temperature | Ecology | Telemetry | Disease control | Esophagus | Zoonoses | Heart rate | Studies | Experimental infection | Infectious diseases | Influenza | Wildfowl | Aircraft | Biological Sciences | Biologi | Naturvetenskap | Natural Sciences | Biologiska vetenskaper
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 2017, Volume 176, Issue 2, pp. 99 - 109
Objective: Few studies have determined the effects of long-term growth hormone (GH) replacement on quality of life (QoL). This study investigated the effects...
REPORTED OUTCOMES | THERAPY | ENDOCRINOLOGY & METABOLISM | RECOMBINANT HUMAN GH | VALUES | FACTOR-I | BODY-COMPOSITION | HEALTH | CONSUMPTION | QOL | Hypopituitarism - physiopathology | Glucocorticoids - therapeutic use | Hormone Replacement Therapy - standards | Prospective Studies | Humans | Middle Aged | Male | Growth Hormone - deficiency | Young Adult | Growth Hormone - therapeutic use | Age of Onset | Quality of Life | Adult | Female | Aged | Deamino Arginine Vasopressin - therapeutic use | Hypopituitarism - drug therapy
REPORTED OUTCOMES | THERAPY | ENDOCRINOLOGY & METABOLISM | RECOMBINANT HUMAN GH | VALUES | FACTOR-I | BODY-COMPOSITION | HEALTH | CONSUMPTION | QOL | Hypopituitarism - physiopathology | Glucocorticoids - therapeutic use | Hormone Replacement Therapy - standards | Prospective Studies | Humans | Middle Aged | Male | Growth Hormone - deficiency | Young Adult | Growth Hormone - therapeutic use | Age of Onset | Quality of Life | Adult | Female | Aged | Deamino Arginine Vasopressin - therapeutic use | Hypopituitarism - drug therapy
Journal Article
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 121 - 130
Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk...
MEDICINE, GENERAL & INTERNAL | BASE-LINE | EVENTS | EFFICACY | SAFETY | PEPTIDE-1 RECEPTOR AGONISTS | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Elderly
MEDICINE, GENERAL & INTERNAL | BASE-LINE | EVENTS | EFFICACY | SAFETY | PEPTIDE-1 RECEPTOR AGONISTS | Myocardial infarction | Heart attacks | Peptides | Control methods | Glucagon | Clinical trials | Cardiovascular disease | Population studies | Cancer therapies | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Glucagon-like peptide 1 | Women | Cerebral infarction | Enzymes | Stroke | Middle age | Diabetes mellitus | Health risks | Hypoglycemia | Risk analysis | Angina pectoris | Disease control | Cholesterol | Thyroid cancer | Agonists | Diabetes | Cardiovascular diseases | Health risk assessment | Elderly
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 11/2019
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e98024
Objective: To validate diagnostic codes for psoriasis and psoriatic arthritis (PsA) and estimate physician-diagnosed prevalence of psoriasis and PsA in the...
PLAQUE PSORIASIS | MULTIDISCIPLINARY SCIENCES | DATABASES | QUALITY-OF-LIFE | EPIDEMIOLOGY | CARE | ECONOMIC BURDEN | Arthritis, Psoriatic - epidemiology | International Classification of Diseases | Reproducibility of Results | Prevalence | Physicians | Humans | Middle Aged | Psoriasis - diagnosis | Arthritis, Psoriatic - diagnosis | Male | Sweden - epidemiology | Psoriasis - epidemiology | Adult | Female | Registries | Population Surveillance | Medical records | Health aspects | Psoriatic arthritis | Health care | Codes | Sensitivity analysis | Psoriasis | Health services utilization | Health care policy | Population studies | Arthritis | Epidemiology | Patients | Primary care | Inflammatory diseases | Quality of life | Studies | Validity | Hospitals | Health care expenditures | Orthopedics | Diagnostic systems | Trends | Inhabitants | Clinical Medicine | Hälsovetenskap | Health Care Service and Management, Health Policy and Services and Health Economy | Medical and Health Sciences | Medicin och hälsovetenskap | Dermatologi och venereologi | Dermatology and Venereal Diseases | Klinisk medicin | Ortopedi | Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi | Health Sciences
PLAQUE PSORIASIS | MULTIDISCIPLINARY SCIENCES | DATABASES | QUALITY-OF-LIFE | EPIDEMIOLOGY | CARE | ECONOMIC BURDEN | Arthritis, Psoriatic - epidemiology | International Classification of Diseases | Reproducibility of Results | Prevalence | Physicians | Humans | Middle Aged | Psoriasis - diagnosis | Arthritis, Psoriatic - diagnosis | Male | Sweden - epidemiology | Psoriasis - epidemiology | Adult | Female | Registries | Population Surveillance | Medical records | Health aspects | Psoriatic arthritis | Health care | Codes | Sensitivity analysis | Psoriasis | Health services utilization | Health care policy | Population studies | Arthritis | Epidemiology | Patients | Primary care | Inflammatory diseases | Quality of life | Studies | Validity | Hospitals | Health care expenditures | Orthopedics | Diagnostic systems | Trends | Inhabitants | Clinical Medicine | Hälsovetenskap | Health Care Service and Management, Health Policy and Services and Health Economy | Medical and Health Sciences | Medicin och hälsovetenskap | Dermatologi och venereologi | Dermatology and Venereal Diseases | Klinisk medicin | Ortopedi | Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi | Health Sciences
Journal Article
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 131 - 138
Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the...
MEDICINE, GENERAL & INTERNAL | BASE-LINE | LIRAGLUTIDE | INCRETIN | CARDIOVASCULAR OUTCOMES | DISEASE | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment
MEDICINE, GENERAL & INTERNAL | BASE-LINE | LIRAGLUTIDE | INCRETIN | CARDIOVASCULAR OUTCOMES | DISEASE | Myocardial infarction | Therapy | Peptides | Glucagon | Cardiovascular disease | Risk factors | Incidence | Randomization | Motivation | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Epidermal growth factor receptors | Diabetes mellitus | Health risks | Risk analysis | Disease control | Agonists | Microvasculature | Diabetes | Kidney diseases | Renal replacement therapy | Gastrointestinal surgery | Cardiovascular diseases | Health risk assessment
Journal Article